Table 2.
Characteristics of young and middle-aged patients.
| Variables | Severe (n = 69) | Critical (n = 16) | P value | |
|---|---|---|---|---|
| Complete blood count | ||||
| Hemoglobin, g/L | 129 (122, 139) (n = 69) | 133 (115, 134) (n = 16) | 0.51 | |
| Leukocytes, ×109/L | Admission | 5.2 (4.4, 6.4) (n = 69) | 7.4 (5.0, 16.2) (n = 16) | 0.01 |
| In hospital | 5.5 (4.7, 6.9) (n = 50) | 11.8 (6.7, 22.5) (n = 12) | 0.00 | |
| Neutrophil percentage, % | 58.1 (50.5, 65.3) (n = 69) | 82.4 (72.4,88.0) (n = 16) | 0.00 | |
| Leukocyte percentage, % | 30.1 (24.3, 35.4) (n = 69) | 6.9 (3.9, 15.3) (n = 16) | 0.00 | |
| Platelet, ×109/L | 278 (211, 334) (n = 67) | 175.5 (127, 305) (n = 16) | 0.03 | |
| Liver and renal function | ||||
| ALT, U/L | 22 (15, 37) (n = 69) | 38 (24, 52.5) (n = 16) | 0.01 | |
| AST, U/L | 21 (17, 28) (n = 69) | 53.5 (30.5, 67.3) (n = 16) | 0.00 | |
| Albumin, g/L | 38.9 (35.1, 41.4) (n = 69) | 33.5 (30.2, 37.5) (n = 16) | 0.00 | |
| Total bilirubin (TBIL), μmol/L | 7.1 (4.9, 9.7) (n = 69) | 9.5 (6.6, 13.6) (n = 16) | 0.04 | |
| Direct bilirubin (DBIL), μmol/L | 3.1 (2.2, 4.2) (n = 69) | 4.5 (3.3, 7.7) (n = 16) | 0.00 | |
| ALP, U/L | 67 (55, 82) (n = 69) | 83.5 (66, 126) (n = 16) | 0.01 | |
| GGT, U/L | 24 (17.5, 48) (n = 69) | 54.0 (32.5, 92.3) (n = 16) | 0.00 | |
| Blood urea nitrogen (BUN), mmol/L | 4.0 (3.2, 5.0) (n = 69) | 7.8 (5.1, 9.8) (n = 15) | 0.00 | |
| Creatinine, μmol/L | 64.5 (52.3, 79.8) (n = 84) | 72.0 (60.0, 88.0) (n = 188) | 0.01 | |
| GFR, ml/min | 102.5 (97.3, 112.1) (n = 69) | 89.7 (74.9, 113.5) (n = 15) | 0.08 | |
| Cardiovascular function | ||||
| proBNP, ng/L | 51 (28, 113) (n = 55) | 408 (70, 769) (n = 11) | 0.01 | |
| cTnI, ng/L | 2.2 (1.9, 6.1) (n = 61) | 13.0 (4.1, 215.4) (n = 14) | 0.00 | |
| Inflammatory biomarkers | ||||
| Procalcitonin (PCT), ng/mL | 0.06 (0.05, 0.08) (n = 27) | 0.32 (0.21, 0.62) (n = 9) | 0.00 | |
| hsCRP, mg/L | Admission | 5.0 (1.05, 19.25) (n = 69) | 89.7 (29.1, 187.8) (n = 16) | 0.00 |
| In hospital | 1.35 (0.83, 7.6) (n = 44) | 153 (89.2, 229.8) (n = 14) | 0.00 | |
| hsCRP fluctuation, mg/L | −2.95 (-16.25, −0.1) (n = 44) | 67.9 (36.9, 77.1) (n = 14) | 0.00 | |